Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31,294,939
-
Number of holders
-
261
-
Total 13F shares, excl. options
-
29,041,225
-
Shares change
-
+20,444
-
Total reported value, excl. options
-
$3,247,601,939
-
Value change
-
+$3,747,736
-
Put/Call ratio
-
41%
-
Number of buys
-
131
-
Number of sells
-
-115
-
Price
-
$111.83
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q4 2019
291 filings reported holding CNMD - CONMED Corp - Common Stock as of Q4 2019.
CONMED Corp - Common Stock (CNMD) has 261 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29,041,225 shares
of 31,294,939 outstanding shares and own 93% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4,348,855 shares), VANGUARD GROUP INC (3,000,096 shares), Capital Research Global Investors (2,156,651 shares), DIMENSIONAL FUND ADVISORS LP (1,284,761 shares), Champlain Investment Partners, LLC (1,125,540 shares), STATE STREET CORP (903,517 shares), MACQUARIE GROUP LTD (746,532 shares), PRINCIPAL FINANCIAL GROUP INC (709,837 shares), NORTHERN TRUST CORP (638,482 shares), and HealthCor Management, L.P. (536,020 shares).
This table shows the top 261 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.